Parkinson protein 2 (PARK2), a well‐characterized RBR E3 ubiquitin ligase, has been found to exert tumor‐suppressive effects by inhibiting mitophagy, modulating glucose metabolism, and reducing mitochondrial respiration.[35, 36] Elodie et al. The gene discussed is PRKN; the disease is neoplasm.